Twitxy Saved

Sam Finlayson

Verified account This account is verified. Learn more

@IAmSamFin

AI and Rare Disease.
Current: Life Science @AnthropicAI and Clinical Genetics @seattlechildren
Past: @OpenEvidence, MD-PhD @harvardmed / @MIT_CSAIL, @Stanford
Seattle, WA samfinlayson.com Joined October 2014
745 Following 6K Followers 10K Posts

Latest posts 5

Sam Finlayson Verified account @IAmSamFin
Career update/news including that I'm hiring!

Late in the summer, I made the jump to @AnthropicAI to help co-lead a moonshot effort in genetic medicine.

I'm hoping to have a proper update to share publicly fairly soon, but if you know my collection of interests (AI, clinical genetics, therapeutics, rare disease non-profits), you are unlikely to be surprised. Much of the upfront effort here requires infra for moving atoms as well as bits, and we explicitly want to lean deeply into collaborations with academics, non-profits, and key industry partners in the space. If either of the below roles sound like you, please apply through the link. More to come!

Program Manager:
job-boards.greenhouse.io/anthropic/jobs…

CMC and Manufacturing Lead:
job-boards.greenhouse.io/anthropic/jobs…
job-boards.greenhouse.io Technical Program Manager, Life Sciences Research (Genetic Medicine) Boston, MA; San Francisco, CA | New York City, NY | Seattle, WA
35 replies 26 reposts 456 likes 38K views View on X
Sam Finlayson Verified account @IAmSamFin
Labor of love here, more than a year in the making 👇
Emily Alsentzer @Emily_Alsentzer Nov 3
🚨Introducing the SAIL Therapeutic Actionability AI Challenge🚨

~450M people have a rare disease, often facing decades-long journeys to find therapies. <10% of rare diseases have an FDA-approved one.

We think AI can help close this gap.

Submit your model by Jan 5.
Details 👇
View quoted post on X
3 replies 6 reposts 26 likes 2.1K views View on X
Sam Finlayson Verified account @IAmSamFin
I’ve long felt that @OpenEvidence query data is the medical equivalent of the Google street view cameras, providing a first-hand look at how clinicians navigate the terrain of clinical knowledge, both knowns and unknowns.

IMO there is so much utility in using these data to discover trends in our practice, holes in our guidelines, emerging clinical needs, opportunities for impact.

But obviously, any mining of these data has to be approached with great care, for patient safety and clinician trust. This paper is a first measured step in publishing trends from OE data (other than implicitly through work with, eg society guidelines). It focuses on basic trends in who is using the platform and for what purpose. Excited to see it out. So much fun working with @TravisZack2 and our colleagues from Harvard on this.

Other efforts are in the works and I hope there is much more to come in the genre of @OpenEvidence -> new evidence.
In @JAMA_current led by @vrpatel97, @IAmSamFin and @AnupamBJena: how are US 👨‍⚕️ actually using AI? We analyzed 271M queries from 950K+ clinicians on @OpenEvidence over 2.5 years. Monthly active users grew from 355 to 700K+, and 9/10 kept coming back.

Link: jamanetwork.com/journals/jama/…
View quoted post on X
6 replies 11 reposts 91 likes 11K views View on X